最新全球10大医疗器械公司：美敦力领跑，强生营收下降！

admin

                    

                    

                    
                    
                    <section data-role="paragraph" data-color="rgb(182, 228, 253)" data-custom="rgb(182, 228, 253)"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section powered-by="gulangu"><section><section><section><section><p><p><img src="image/20201014/86b79d371e9862b01189f0252a03b2cd_1.png" /></p></p></section><section><section><span><strong></strong></span></section><p><span>医疗器械媒体报道先锋</span></p><p><span>分享专业医疗器械知识</span></p></section><section><section><section><span>关注</span></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section></section><p>&nbsp;</p><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span>医疗器械是生命科学领域发展最快的领域之一，这个庞大的产业开发了各种各样的设备，从诊断、影像到外科、整形手术，近年来，随着科技水平的提高，医疗设备结合创新软件技术推动了这个医疗健康技术的子行业呈指数增长，对健康技术和人工智能的投资也大大增加。</span></p><p><br  /></p><p><span>国外权威网站QMED最近编制了世界上10大医疗设备公司的名单，按照其2019年的营收进行排名如下（单位：亿美元）：</span></p></section><section powered-by="gulangu"><p><br  /></p></section><section powered-by="gulangu"><section><p><img src="image/20201014/61ac3832f29a8b1884ac3db9ded862bb_2.jpg" /></p></section></section></section></section></section></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><br  /></p><p><span><strong>美敦力</strong></span></p><p><span><strong><br  /></strong></span></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/5c0a9eb097daef587b13000a90ca725f_3.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><br  /></p><p><span>2019年，美敦力实现年收入308.91亿美元，同比增长2%。主要归功于旗下糖尿病业务和恢复性疗法业务增长幅度较大，分别为12%和6%。</span></p><p><br  /></p><p><span>在2019年8月，美敦力发表了一份CEO继任计划，美敦力公司首席执行官Omar Ishrak将在经过近9年的掌舵后，在2020财年结束后退休。由现任公司恢复治疗业务部门（RTG）总裁Geoff Martha，担任美敦力总裁新任职务。</span></p><p><br  /></p><p><span>据悉，2020年，美敦力将继续执行治疗创新、全球化、经济价值三大核心战略。</span></p><p><br  /></p></section></section></section></section></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong><span>强生</span></strong></span></p><p><span><br  /></span></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/82434687f9b7e85320c60006e70cc52e_4.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><span><br  /></span></p><p><span>强生医疗在这一年里进入了医疗技术最热门的领域之一，在Auris Health和其Monarch机器人辅助支气管镜检查平台上花费了34亿美元，用Verb Surgical和矫形外科来补充机器人辅助普外科计划，并且收购骨科平台。</span></p><p><br  /></p><p><span>2019年，强生总营收达259.63亿美元，同比去年下跌了3.8%。其主要原因在于强生继续重组医疗器械部门，进行了两项资产剥离：以28亿美元的价格将其先进的消毒产品业务出售给Fortive，并以21亿美元的价格出售旗下的Lifecan血糖监测子公司Platinum Equity。</span></p><p><br  /></p></section></section></section></section></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong><span>雅培</span></strong></span></p><p><span><br  /></span></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/d44376f288615b17cbfdbb122c93f5b8_5.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><span><br  /></span></p><p><span>2019年，雅培实现总体营收199.52亿美元，同比增长6%。从2018的第11名一跃成为第3名，主要因为旗下糖尿病业务增长迅速，同比去年增长了30.6%。此外，诊断业务同比增长2.9%，医疗设备业务同比增长7.6%。</span></p><p><br  /></p><p><span>2020年，雅培的CEO Miles White将于3月底正式卸任，由雅培总裁兼首席运营官Robert Ford接任。</span></p><p><br  /></p><p><span>据悉，2020年，雅培将继续开展并购工作。</span></p><p><span></span></p></section></section></section></section></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong>GE</strong></span></p><p><br  /></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/ee0cbb6d3d813e3f270bc7df14a3d174_6.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><br  /></p><p><span>GE医疗在经历了动荡的一年后，仍未独立上市。</span></p><p><br  /></p><p><span>在2019年财报中，GE年总营收达199.42亿美元，同比增长1%。据悉，GE医疗全球总裁兼执行官Kieran Murphy表示，GE医疗目前的主要工作就是将资源投入到与新一代公司的合作中，帮助改变医生的工作方式，实现更精准的患者护理。</span></p></section></section></section><section powered-by="gulangu"><section><p><br  /></p></section></section></section></section><section powered-by="gulangu"><section><br  /></section></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong><span>费森尤斯</span></strong></span></p><p><span><strong><span><br  /></span></strong></span></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/fd47cfb724cd127376b8df66c98938d2_7.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><span><br  /></span></p><p><span>费森尤斯医疗是慢性肾脏病护理领域全球最大的医疗设备公司，为全球30多万患者提供透析产品及服务。该公司已成为全球透析市场的领导者。</span></p><p><br  /></p><p><span>有关费森尤斯最大的消息是，今年2月美国联邦贸易委员会批准德国费森尤斯和美国家庭透析设备制造商NxStage Medical Inc的合并。美国联邦贸易委员会表示，为了达成20亿美元交易的批准，两家公司同意出售NxStage的血管套装（bloodline tubing set)业务。</span></p><p><br  /></p><p><span>2019年7月，由于特朗普政府计划彻底改革肾脏治疗市场，寻求降低联邦政府每年1000亿美元的肾脏护理费用的消息，该公司股票受到重创。该策略涉及美国卫生与公共服务部的新支付模式，旨在将患者从费森尤斯的血液透析诊所转移到自己的家中接受治疗；卫生与公众服务部还计划增加肾脏疾病的预防和筛查。</span></p></section></section></section><section powered-by="gulangu"><section><p><br  /></p></section></section></section></section><section powered-by="gulangu"><p><br  /></p></section><section powered-by="gulangu"><span><strong><span>BD</span></strong></span></section><section powered-by="gulangu"><span><br  /></span></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/ff4b41352bf07b5e39a32af82d0d6e01_8.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><span><br  /></span></p><p><span>BD是全球最大的研发、生产和销售医疗设备，医疗系统和试剂的医疗技术公司之一，专注于改进药物传输，提高传染性疾病和癌症诊断的质量和速度，推进新型药物和疫苗的研发与生产。</span></p><p><br  /></p><p><span>在2019年的财报中，BD实现总体营收172.90亿美元，同比增长8%。在旗下业务方面，生命科学业务小幅下滑，同比下跌0.7%，其余医疗部门以及介入部门分别增长5.2%、29.3%。</span></p><p><span></span></p></section></section></section></section></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong><span>西门子</span></strong></span></p><p><span><br  /></span></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/bd213d49b7d148f126c858fe9f174e9c_9.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><span><br  /></span></p><p><span>西门子医疗是医疗成像系统的主要制造商，包括计算机断层成像、核磁共振成像、分子成像、X射线和超声波。该公司还生产用于图像引导治疗的血管造影系统、移动c臂和混合手术室，以及诊断测试系统，其他服务包括软件和临床咨询。</span></p><p><br  /></p><p><span>据财报显示，西门子2019年总营收为160.90亿美元，同比增长8%。旗下影像业务增长10%，诊断业务增长4%，临床治疗业务增长9%。</span></p><p><br  /></p><p><span>在2019年中，西门子先后收购了美国机器人辅助血管介入的全球技术领导者Corindus，以及美国医疗咨询公司ECG从而对临床诊疗业务和医疗服务进行强化。</span></p><p><br  /></p></section></section></section></section></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong><span>嘉德诺</span></strong></span></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><br  /></p></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/6719bd7a5a041cfa47c6f40a54588dfe_10.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><span><br  /></span></p><p><span>作为美国药械流通的三巨头之首，其于2019年3月正式中国更新中文品牌名称“嘉德诺”。</span></p><p><br  /></p><p><span>自Cardinal Health斥资19.4亿美元收购强生公司（Johnson&amp;Johnson）的Cordis以来，已有四年时间了，但该公司仍在努力应对与支架、气球和其他介入性心脏病产品制造商有关的挑战。</span></p><p><br  /></p><p><span>2019年8月，嘉德诺首席执行官迈克考夫曼（mike kaufmann）就曾在电话会议中透露，“Cardinal Health为其医疗业务引入了一种新的销售结构，并正在进行一个漫长的过程，以转换其制造、供应链和数据能力。2019年，嘉德诺的重点仍然围绕着产品收购的执行与并购。</span></p><p><br  /></p><p><span>目前，嘉德诺2019年财报尚未公布，业务增长情况还不明确。</span></p></section></section></section><section powered-by="gulangu"><section><p><br  /></p></section></section></section></section><section powered-by="gulangu"><p><br  /></p></section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong><span>飞利浦</span></strong></span></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><br  /></p></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><p><img src="image/20201014/216eb43d158a2fc61bfe0b9141abb500_11.jpg" /></p></section></section></section><section><section powered-by="gulangu"><p><br  /></p><p><span>飞利浦医疗2019年1月重组，将睡眠和呼吸部分从个人健康转移到新的互联医疗部门，并将医疗信息学转移到诊断和治疗部分。在新的架构下，飞利浦有三个部门：诊断与治疗部、联保部和个人健康部。</span></p><p><br  /></p><p><span>2019年，飞利浦总体营收为146.06亿美元，同比增长9%。旗下两大核心医疗业务均有小幅增长，诊断与治疗部同比增长10%，联保部同比增长8%。</span></p><p><br  /></p><p><span>据悉，2020年，飞利浦将重点发展精确诊断和以图像为主的微创解决方案，以及贯穿医院内外的患者护理解决方案。</span></p><p><br  /></p></section></section></section></section></section><section powered-by="gulangu"><section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><section powered-by="gulangu"><p><span><strong><span>史赛克</span></strong></span></p><p><span><br  /></span></p><p><p><img src="image/20201014/0a4f0a710cb4c8f52111361dff4f25af_12.jpg" /></p></p></section></section></section></section></section></section></section></section><section><section powered-by="gulangu"><section><section powered-by="gulangu"><section><br  /></section></section></section><section><section powered-by="gulangu"><p><br  /></p><p><span>作为全球最大的骨科医疗器械公司之一，史赛克主要从事医疗产品的开发，生产与销售。公司产品包括植入物用于关节置换和创伤外科；手术器械和手术导航系统；内窥镜和通信系统；病人管理、急救医疗设备；神经外科，神经和脊髓的装置；以及其他医疗器械产品用于各种医疗专业。</span></p><p><br  /></p><p><span>据最新发布的财报显示，2019年史赛克总体营收为148.84亿美元，同比上涨9.43%。各个业务方面增长稳定，骨科业务同比增长5.2%，医疗外科手术同比增长8.8%，神经脊柱业务增长迅速，同比去年增长了19.2%。</span></p><p><br  /></p><p><span>在2019年中，史赛克的收购脚步逐渐加快，通过对移动诊断成像公司Mobius 、介入放射机器人导航Cardan的收购从而快速打进脊柱术中成像领域，也直接促使了神经脊柱业务的迅速增长。此外，在骨科以及微创外科手术方面，史赛克也是进行了不断地布局，先后对OrthoSpace、Wright Medical Group进行了大手笔的收购。</span></p></section></section></section><section powered-by="gulangu"><section><p><br  /></p></section></section></section></section></section><section powered-by="gulangu"><p><br  /></p></section><section data-role="outer" label="Powered by gulangu"><section data-role="paragraph" data-color="#757576"><section data-role="paragraph"><section><section><section data-brushtype="text"><strong>相关阅读</strong></section></section></section><section><section><br  /></section></section><section data-width="100%"><section><section><section><section data-width="100%"><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><section><p><img src="image/20201014/2aac877ff9233ba5a66e7a5ff3a4febf_13.gif" /></p></section><section data-brushtype="text">戳一下，更有料！</section></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652973171&amp;idx=1&amp;sn=4fc7d0c13dc468edd6669da4b68cf32e&amp;chksm=843f4ae4b348c3f2fb3f4e9ab5c0ccc9657e4cc2959c227ac792925afd5f0e1233c122004165&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>GE医疗首推全流程AI磁共振技术平台“智简AI” ，开启MR+AI 3.0时代</span></a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652973134&amp;idx=1&amp;sn=032dfeeeba88b7043c04452dbbac381d&amp;chksm=843f4ad9b348c3cf612f90fce313bf5ead288eeee0ce1dcf5a882310a7041f697c32a9ee4b82&amp;scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2"><span>关于方舱CT的一切！</span></a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652973131&amp;idx=1&amp;sn=e16b95b4d0fbccf63c90469e1938b2ea&amp;chksm=843f4adcb348c3cabb7d77fe8d4f499e684c982759ce9878be8c2b6922fd69e492aae78f7774&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>我国首台自主知识产权重离子治疗系统完成首例患者治疗！</span></a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652973131&amp;idx=2&amp;sn=c5bf2c0809bf3bc8a941b8a42e0b6deb&amp;chksm=843f4adcb348c3ca4b4a353053b93f539e690be5584195cd73e170951bf6f894b5e31881e4ce&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>正式登陆中国，顶级手术机器人ROSA One通过NMPA审核</span></a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652973070&amp;idx=1&amp;sn=57734440324824393ca57f9929bd1486&amp;chksm=843f4a99b348c38f3b37d075aa6132ada223a391106d36197b38ce5574b2ec047fa872632e1c&amp;scene=21#wechat_redirect" textvalue="全球紧缺的ICU究竟需要哪些设备？" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>全球紧缺的ICU究竟需要哪些设备？</span></a></p><p><br  /></p><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652973064&amp;idx=1&amp;sn=0bedc48c46e2a273939dd44d31f36d27&amp;chksm=843f4a9fb348c389d709a3498969fb1d843f0c9a5a3ea5a61a130fb22e2031877838be665be3&amp;scene=21#wechat_redirect" textvalue="江湖救急！各国都缺的呼吸机，这些厂家生产！" data-itemshowtype="0" tab="innerlink" data-linktype="2"><span>江湖救急！各国都缺的呼吸机，这些厂家生产！</span></a></p><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652972972&amp;idx=3&amp;sn=4c5810961c7d9b1726e6653320d2e37f&amp;chksm=843f453bb348cc2d28e717fc16629f2c615b62b74ac95488eba82d781f8ead319d61835f1e13&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">新冠病毒检测试剂盒研发技术不断突破，检测时间最快2分钟</a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652972959&amp;idx=1&amp;sn=23767c0caba81e82cb4d0b3c226b2aed&amp;chksm=843f4508b348cc1e9fa631afb2b7ca4772f8a61c16818a927be204e33c6ea4780e1f1cd04edc&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">中国医疗器械正在拯救世界</a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652972959&amp;idx=3&amp;sn=f205765406b93a40c2e4d56d626bcccc&amp;chksm=843f4508b348cc1e3309f33492ce4d7e2d8115871d04a93433ce5821e2e8734b0f03e59d705b&amp;scene=21#wechat_redirect" data-itemshowtype="11" tab="innerlink" data-linktype="2" hasload="1">新型HIV即时诊断设备面世，适用于医疗资源匮乏地区</a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652972959&amp;idx=4&amp;sn=2306d86c1050dce51ff5672ccc13ea98&amp;chksm=843f4508b348cc1eed63deec083bd38c6f030ba0389bbf234b9b0bb7f85a2a8389a093b1ad0b&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">阿里健康换帅！</a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652972944&amp;idx=1&amp;sn=9b8b79733f81ee1e5a6d6d8804dbb438&amp;chksm=843f4507b348cc118366b8a470a770351a3d4c5742be59a34bdfde208cc37ad949863959dc87&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">百度再入医疗，这次会以怎样的结局收场？</a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652972944&amp;idx=2&amp;sn=5e543f36e659dcc43551503b0748a588&amp;chksm=843f4507b348cc1132c6cb4daeb27f1212cfd8a74ca23aea8979a492aa0cbeb314613c43d98c&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">英国提出的“群体免疫”是愚弄百姓一个弥天大谎！</a><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><br  /></section><section data-tools="gulangu" data-id="87578" data-color="#6aa9ad" data-custom="#59c3f9"><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA4NDIwMzUxMg==&amp;mid=2652972944&amp;idx=3&amp;sn=d133612979ec5df888a579212157f644&amp;chksm=843f4507b348cc117fe9b6d38b5b03983aa0cb2f6db600d0202b39de71aaf39bcf21c67bfcb8&amp;scene=21#wechat_redirect" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">中国IVD企业，正在支援全球</a></section></section></section></section></section></section></section></section></section><p><br  /></p><p><p><img src="image/20201014/aad9f56b0707b5374bbac6273a663447_14.jpg" /></p></p>